CovidVax | show full list |
limited distribution: December 2020 (45 million doses) mass distribution: Q4 2021 (1.3 billion doses) |
PHASE 1-2 (Mainz, Ger)
started April 20 2020 with 444 healthy volunteers aged 56-85 trial location: Mainz, Germany |
PHASE 1-2 (Berlin, Ger)
started April 23 2020 with 456 healthy volunteers aged 18-85 trial location: Berlin and Mannheim, Germany |
PHASE 1-2 (China)
started July 21 2020 with 144 healthy volunteers aged 18+ trial location: China |
PHASE 1-2 (Germany)
started September 9 2020 with 120 healthy volunteers aged 18-85 trial location: Berlin, Germany |
PHASE 1 (Japan)
started October 21 2020 with 160 healthy volunteers aged 20-85 trial location: Japan |
PHASE 2 (China)
started December 2 2020 with 960 healthy volunteers aged 18-85 trial location: China |
PHASE 2-3 (USA)
started April 29 2020 with 43998 healthy volunteers aged 18-85 trial location: USA |
start date: April 2020 developed 4 vaccine candidates |
currently no early development info |
Sep 15 | BioNTech will receive up to 375 million Euro from BMBF to support BNT162 vaccine program (by biontech.de) |
Jun 03 | Trump Administration has selected BioNTech vaccine among top 5 most likely to be produced (by nytimes.com) |
Oct 08 | BioNTech-Pfizer reached a deal with Rentschler Biopharma to handle the purification process for the pair's mRNA-based COVID 19 vaccine (by fiercepharma.com) |
Jul 28 | URMC and RRH are joining a phase 3 clinical trial for the vaccine developed by Pfizer/BioNTech (by rochester.edu) |
Jul 22 | BioNTech-Pfizer announced agreement with U.S Government for up to 600M doses of their vaccine (by businesswire.com) |
Apr 09 | Pfizer will fund 100% of the vaccine development costs and pay BioNtech $185M (by businesswire.com) |
Mar 16 | Fosun is set to pay BioNTech up to $135M to share profits of the vaccine in China (by fiercebiotech.com) |